BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pokorska-Śpiewak M, Stańska-Perka A, Popielska J, Ołdakowska A, Coupland U, Zawadka K, Szczepańska-Putz M, Marczyńska M. Prevalence and predictors of liver disease in HIV-infected children and adolescents. Sci Rep 2017;7:12309. [PMID: 28951598 DOI: 10.1038/s41598-017-11489-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Basile FW, Fedele MC, Lo Vecchio A. Gastrointestinal Diseases in Children Living with HIV. Microorganisms 2021;9:1572. [PMID: 34442651 DOI: 10.3390/microorganisms9081572] [Reference Citation Analysis]
2 Tadesse BT, Foster BA, Kabeta A, Ayalew F, H/Meskel G, Jerene D, Makonnen E, Aklillu E. Hepatic and renal toxicity and associated factors among HIV-infected children on antiretroviral therapy: a prospective cohort study. HIV Med 2019;20:147-56. [PMID: 30474906 DOI: 10.1111/hiv.12693] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Platt L, French CE, McGowan CR, Sabin K, Gower E, Trickey A, McDonald B, Ong J, Stone J, Easterbrook P, Vickerman P. Prevalence and burden of HBV co-infection among people living with HIV: A global systematic review and meta-analysis. J Viral Hepat. 2020;27:294-315. [PMID: 31603999 DOI: 10.1111/jvh.13217] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
4 Carrasco I, Olveira A, Lancharro Á, Escosa L, Mellado MJ, Busca C, Montes ML, Díez C, Alcolea-Ruiz S, Navarro ML, Sainz T. Prevalence of nonalcoholic fatty liver disease using noninvasive techniques among children, adolescents, and youths living with HIV. AIDS 2022;36:805-14. [PMID: 35013082 DOI: 10.1097/QAD.0000000000003170] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Gouvêa AFTB, Filho RC, Machado DM, Bononi do Carmo F, Beltrão SV, Sampaio L, de Moraes-Pinto MI, Succi RCM. Assessment of liver disease by non-invasive methods in perinatally infected Brazilian adolescents and young adults living with Human Immunodeficiency Virus (HIV). Braz J Infect Dis 2021;25:101589. [PMID: 34147474 DOI: 10.1016/j.bjid.2021.101589] [Reference Citation Analysis]
6 Tamandjou Tchuem CR, Brandt L, Nel ER, Cotton MF, Matthews P, Kaindjee-Tjituka F, Preiser W, Andersson MI. Hepatitis B virus drug resistance mutations in HIV/HBV co-infected children in Windhoek, Namibia. PLoS One 2020;15:e0238839. [PMID: 32915862 DOI: 10.1371/journal.pone.0238839] [Reference Citation Analysis]
7 Coronel-Castillo CE, Qi X, Contreras-Carmona J, Ramírez-Pérez OL, Méndez-Sánchez N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious disease. Expert Rev Gastroenterol Hepatol 2019;13:531-40. [PMID: 30905208 DOI: 10.1080/17474124.2019.1599284] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
8 Bakasis AD, Androutsakos T. Liver Fibrosis during Antiretroviral Treatment in HIV-Infected Individuals. Truth or Tale? Cells 2021;10:1212. [PMID: 34063534 DOI: 10.3390/cells10051212] [Reference Citation Analysis]
9 Rose PC, Nel ED, Cotton MF, Pitcher RD, Otwombe K, Browne SH, Innes S. Prevalence and Risk Factors for Hepatic Steatosis in Children With Perinatal HIV on Early Antiretroviral Therapy Compared to HIV-Exposed Uninfected and HIV-Unexposed Children. Front Pediatr 2022;10:893579. [PMID: 35757117 DOI: 10.3389/fped.2022.893579] [Reference Citation Analysis]
10 Rasoulinejad M, Seyed Alinaghi SA, Sohrabi MR, Badie BM, Manshadi SAD, Nezhad MH, Khatami SR. Prevalence and Factors Associated with Hepatic Steatosis and Fibrosis Using Fibroscan in HIV-positive Patients Treated with Anti-retroviral (ARV) Medicines Referred to the Biggest Hospital in Tehran, 2018 to 2019. TOAIDJ 2020;14:108-13. [DOI: 10.2174/1874613602014010108] [Reference Citation Analysis]